Update on the management of status epilepticus.
Rossetti AO, Alvarez V.
Curr Opin Neurol. 2021 Apr 1;34(2):172-181. doi: 10.1097/WCO.0000000000000899.
Cefepime-induced neurotoxicity: systematic review.
Maan G, Keitoku K, Kimura N, Sawada H, Pham A, Yeo J, Hagiya H, Nishimura Y.
J Antimicrob Chemother. 2022 Oct 28;77(11):2908-2921. doi: 10.1093/jac/dkac271.
Status epilepticus in Hashimoto's encephalopathy.
Ercoli T, Defazio G, Muroni A.
Seizure. 2019 Aug;70:1-5. doi: 10.1016/j.seizure.2019.06.020. Epub 2019 Jun 13.
WARS2 Deficiency.
Mroczek M, Busra A, Houlden H, Efthymiou S, Nagy S.
2023 Oct 12. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024.
Perampanel in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus.
Strzelczyk A, Willems LM, Willig S, Rosenow F, Bauer S.
Expert Rev Clin Pharmacol. 2015;8(6):733-40. doi: 10.1586/17512433.2015.1091303. Epub 2015 Oct 5.
Progressive Myoclonus Epilepsy, Lafora Type.
Jansen AC, Andermann E.
2007 Dec 28 [updated 2019 Feb 21]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024.
Atypical Rasmussen's encephalitis presenting as focal status epilepticus and periodic generalised myoclonus.
Rudrabhatla PK, Mehnaz F, Metta S.
Acta Neurol Belg. 2023 Dec;123(6):2431-2433. doi: 10.1007/s13760-023-02267-1. Epub 2023 Apr 10.
Brivaracetam in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus.
Strzelczyk A, Klein KM, Willems LM, Rosenow F, Bauer S.
Expert Rev Clin Pharmacol. 2016;9(5):637-45. doi: 10.1586/17512433.2016.1156529. Epub 2016 Mar 7.
Epileptic encephalopathy.
Dulac O.
Epilepsia. 2001;42 Suppl 3:23-6. doi: 10.1046/j.1528-1157.2001.042suppl.3023.x.
Ceftazidime-related nonconvulsive status epilepticus.
Klion AD, Kallsen J, Cowl CT, Nauseef WM.
Arch Intern Med. 1994 Mar 14;154(5):586-9.
